- Home
- RAPT vs FTHY Comparison
RAPT vs FTHY Comparison
Compare RAPT & FTHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- FTHY
- Stock Information
- Founded
- RAPT 2015
- FTHY 2020
- Country
- RAPT United States
- FTHY United States
- Employees
- RAPT N/A
- FTHY N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- FTHY Investment Managers
- Sector
- RAPT Health Care
- FTHY Finance
- Exchange
- RAPT Nasdaq
- FTHY Nasdaq
- Market Cap
- RAPT 498.4M
- FTHY 539.8M
- IPO Year
- RAPT 2019
- FTHY N/A
- Fundamental
- Price
- RAPT $29.86
- FTHY $14.16
- Analyst Decision
- RAPT Strong Buy
- FTHY
- Analyst Count
- RAPT 8
- FTHY 0
- Target Price
- RAPT $46.75
- FTHY N/A
- AVG Volume (30 Days)
- RAPT 614.9K
- FTHY 176.7K
- Earning Date
- RAPT 11-11-2025
- FTHY 01-01-0001
- Dividend Yield
- RAPT N/A
- FTHY 10.93%
- EPS Growth
- RAPT N/A
- FTHY N/A
- EPS
- RAPT N/A
- FTHY N/A
- Revenue
- RAPT N/A
- FTHY N/A
- Revenue This Year
- RAPT N/A
- FTHY N/A
- Revenue Next Year
- RAPT N/A
- FTHY N/A
- P/E Ratio
- RAPT N/A
- FTHY N/A
- Revenue Growth
- RAPT N/A
- FTHY N/A
- 52 Week Low
- RAPT $5.67
- FTHY $12.66
- 52 Week High
- RAPT $42.39
- FTHY $14.74
- Technical
- Relative Strength Index (RSI)
- RAPT 61.81
- FTHY 39.01
- Support Level
- RAPT $25.50
- FTHY $14.05
- Resistance Level
- RAPT $42.39
- FTHY $14.26
- Average True Range (ATR)
- RAPT 3.91
- FTHY 0.12
- MACD
- RAPT -0.18
- FTHY -0.00
- Stochastic Oscillator
- RAPT 30.92
- FTHY 37.63
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About FTHY First Trust High Yield Opportunities 2027 Term Fund
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.